SCPC Praises Broad Bipartisan Support in U.S. House for 21st Century Cures Act
House-Passed Bill Includes Critical Medicare Part D Exemption Language in Drug Management Program That Protects Long-Term Care Patients
Washington, DC – The Senior Care Pharmacy Coalition (SCPC) today praised House passage of the 21st Century Cures Act, and thanked lawmakers for both recognizing the unique challenges facing long-term care (LTC) pharmacy patients and providers, and for including bill language exempting Part D beneficiaries in skilled nursing facilities and other settings from a previously proposed medication management “lock-in” provision.
“We thank House Energy and Commerce Chairman Fred Upton (R-MI), Ranking Member Frank Pallone (D-NJ) and the full Committee for its vision in crafting this bill, and for the dedication to seeing it through to House passage with such sweeping, broad-based bipartisan support,” stated Alan G. Rosenbloom, President and CEO of SCPC.
“Besides being a strong step forward in finding cures to a variety of the world’s most deadly, persistent diseases, passage of the 21st Century Cures Act is a highly significant policy development that protects LTC patient access to essential medications,” he continued.
Said Rosenbloom: “With passage today, the U.S. House specifically recognizes the unique characteristics of the long-term care patient population and the distinctions between specialized long-term care pharmacies and more common retail pharmacies — particularly the additional requirements imposed on LTC pharmacies under Medicare Part D rules.”
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.